| AEREA Y POSTAL EX-IAAC | 2024 | 33.147 | KG | TASIGNA 200MG, TASIGNA, S/M TASIG HGC 200MG DUP 4(7X4) U17_6 TASIGNA 200MG CAPSULA, EN CAJA DE CARTON CON 112 CAPSULAS EN BLISTER MEDICAMENTO DE USO HUMANO - EE-09020 - PRODUCTO ONCOLOGICO MATERIAL: 755007 - LOTE: NL8184, MFD - EXP: 07/2023 - 06/20 | SWITZERLAND | SWITZERLAND | 395259 |
| AEREA Y POSTAL EX-IAAC | 2024 | 52.448 | KG | TASIGNA 200MG, TASIGNA, S/M TASIG HGC 200MG DUP 4(7X4) U17_6 TASIGNA 200MG CAPSULA, EN CAJA DE CARTON CONN 112 CAPSULAS EN BLISTER MEDICAMENTO DE USO HUMANO - EE-09020 - PRODUCTO ONCOLOGICO MATERFIAL. 755007-LOTE:NP4314 MFD - EXP:10/2023 - 09/2026 | SWITZERLAND | SWITZERLAND | 625401 |
| AEREA Y POSTAL EX-IAAC | 2024 | 1.672 | KG | AFINITOR 10MG, AFINITOR, S/M AFINITOR TAB 10MG ALU 3X10 U17_7 CAJA DE CARTON, EMPAQUE BLISTER DE PA/AL/PVC - ALUMINIO , EXPDTE DE REINSCRIPCION:24018557 MEDICAMENTO DE USO HUMANO // ONCOLOGICO // REGISTRO SANITARIO NO: EE-08550 CODIGO: 755270 - LOTE: | SWITZERLAND | SWITZERLAND | 124437 |
| AEREA Y POSTAL EX-IAAC | 2024 | 1.748 | KG | AFINITOR, AFINITOR, S/M AFINITOR TAB 10MG ALU 3X10 U17_7 LOTE: SKFN7 - MFD - EXP: 04/2023 VCTO : 03-2026 MEDICAMENTO DE USO HUMANO // ONCOLOGICO CODIGO: 755270 - REGISTRO SANITARIO NO: EE-08550 | SWITZERLAND | BRAZIL | 130203 |
| AEREA Y POSTAL EX-IAAC | 2024 | 17.875 | KG | KISQALI 200MG, KISQALI, S/M KISQALI FCT 200MG ACP 3X21 R65 LOTE: SKXN9, MFD - EXP: 09/2023 - 08/2025 MEDICAMENTO PARA CONSUMO HUMANO MATERIAL : 740052 - EXPEDIENTE: 22090403 | GERMANY | SWITZERLAND | 399794 |
| AEREA Y POSTAL EX-IAAC | 2024 | 6.1 | KG | KISQALI, KISQALI, S/M 100 KIT X 30 TABLETS LEE011 (KISQALI) 200MG SIN VALOR COMERCIAL PRODUCTO PARA ESTUDIO DE ENSAYO CLINICO LOTE: 1010028026 , ING ACTIVO RIBOCICLIB | SINGAPORE | SWITZERLAND | 64498.9 |
| AEREA Y POSTAL EX-IAAC | 2024 | 56.875 | KG | KISQALI FCT 200MG, KISQALI, S/M KISQALI FCT 200MG ACP 3X21 R65 LOTE :SLWD4 MFD - EXP: 12/2023 - 11/2025 MEDICAMENTO PARA CONSUMO HUMANO MATERIAL : 740052 // REGISTRO SANITARIO No. EE-06228 | SINGAPORE | SWITZERLAND | 1272350 |
| AEREA Y POSTAL EX-IAAC | 2024 | 78.167 | KG | NEVANAC 0.1% SUSPENSION OFTALMICA, NEVANAC, S/M NEVAN LDMO 1MG/ML LDPE 5ML (X) PE_1 LOTE: VAV42D, MFD - EXP: 10/2023 - 03/2025 MEDICAMENTO PARA CONSUMO HUMANO (SUSPENSION OFTALMICA) MATERIAL: 761093 - REGISTRO: EE-11256 | BELGIUM | SWITZERLAND | 46282 |
| AEREA Y POSTAL EX-IAAC | 2024 | 85.938 | KG | NEVANAC 0.1% SUSPENSION OFTALMICA, NEVANAC, S/M NEVAN LDMO 1MG/ML LDPE 5ML (X) PE_1 LOTE: VCV03D, MFD - EXP: 11/2023 - 04/2025 MEDICAMENTO PARA CONSUMO HUMANO (SUSPENSION OFTALMICA) MATERIAL: 761093 - REGISTRO: EE-11256 | BELGIUM | SWITZERLAND | 50918.1 |
| AEREA Y POSTAL EX-IAAC | 2024 | 76.18 | KG | DUOTRAV 40ug/ml+5mg/ml, DUOTRAV, S/M DUOTRAV BAK-FREE 1.5ML MM -PE / MUESTRA MEDICA DUOTRAV 40UG/ML + 5MG/ML SOLUCION OFTALMICA, CAJA DE CARTON CON BOLSA CONTENIENDO 01 FRASC MEDICAMENTO PARA CONSUMO HUMANO - REGISTRO SANITARIO NO. EE-05319 MATER | BELGIUM | BELGIUM | 43385.6 |
| AEREA Y POSTAL EX-IAAC | 2024 | 59.04 | KG | AZARGA 10mg/mL +5mg/mL, AZARGA, S/M AZARG LDMO 10/5MG/ML- LDPE 2.5ML MM // REGISTRO: EE-01695 10 MG/ML + 5 MG/ML SUSPENSION OFTALMICA, EN CAJA CONTENIENDO GOTERO DE 5 ML MEDICAMENTO DE USO HUMANO/ MUESTRA MEDICA 741230 / LOTE:1VKJ67B F/F:09/2024, F | BELGIUM | BELGIUM | 26043.8 |
| AEREA Y POSTAL EX-IAAC | 2024 | 68.001 | KG | TRAVATAN 0.004%, TRAVATAN, S/M TRAVATAN 2.5ML-PE // R.D. N° 10780-2022-DIGEMID/DPF/UFMNDYO/MINSA LOTE: VJY32E - F.PROD.: 29/08/2024 - F.EXP.: 07/2026 MEDICAMENTO DE USO HUMANO (SOLUCION OFTALMICA) MATERIAL: 742351 // REGISTRO SANITARIO: EE-8890 | BELGIUM | SWITZERLAND | 67949.8 |
